나노의학 시장 보고서(2026년)

Nanomedicine involves the application of nanotechnology in the field of medicine. It is defined as the use of materials sized between 1 and 100 nanometers that are designed to precisely target tumor cells or key immune cells. Nanomedicine serves as a vital tool for advancing personalized, targeted, and regenerative medicine by enabling the delivery of enhanced drugs, therapies, and implantable medical devices to healthcare providers and patients.

The primary categories of nanomedicine include nanoparticles, nanoshells, nanotubes, nanodevices, and others. Nanoparticles are ultrafine particles, typically ranging from 1 to 100 nanometers in diameter, and are widely utilized in the development of medicines and pharmaceuticals. The various modalities of nanomedicine include diagnostics and therapeutics, and they are applied across areas such as clinical oncology, infectious diseases, clinical cardiology, orthopedics, and other medical fields.

Tariffs have impacted the nanomedicine market by increasing the cost of importing specialized nanomaterials, equipment, and nanoparticles, disrupting the supply chain. High-value segments like nanoparticle-based treatments and nanodevices in regions such as North America and Europe are most affected. Some companies are leveraging local manufacturing and material sourcing to mitigate costs, which can also accelerate domestic innovation and strengthen regional supply resilience, providing selective positive effects on the market.

The nanomedicine market research report is one of a series of new reports from The Business Research Company that provides nanomedicine market statistics, including nanomedicine industry global market size, regional shares, competitors with a nanomedicine market share, detailed nanomedicine market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine industry. This nanomedicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nanomedicine market size has grown rapidly in recent years. It will grow from $375.87 billion in 2025 to $434.77 billion in 2026 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to increasing r&d investments in nanotechnology, rising prevalence of chronic diseases, advancements in nanoparticle synthesis techniques, growing adoption of nanomedicine in oncology, collaborations between pharmaceutical and nanotech companies.

The nanomedicine market size is expected to see rapid growth in the next few years. It will grow to $786.46 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to expansion of precision medicine applications, integration of ai in nanomedicine research, growth in regenerative medicine demand, increasing government funding for nanotech healthcare, development of multifunctional nanodevices. Major trends in the forecast period include targeted drug delivery innovations, regenerative nanomedicine development, personalized therapeutics expansion, nanodevice-based diagnostics, nanoformulation optimization.

The growing burden of complex and chronic diseases worldwide is anticipated to support the expansion of the nanomedicine market during the forecast period. Nanomedicine is increasingly utilized in the treatment of chronic conditions such as cardiovascular diseases, diabetes, cancer, dementia, and others, where it facilitates faster and more efficient drug metabolism within the body. For example, according to the International Federation of Alzheimer's Associations, Alzheimer's Disease International, more than 50 million people globally are affected by dementia, and this number is expected to double every 20 years, reaching 80 million by 2030 and 152 million by 2050. In addition, the global cancer burden is projected to increase to 28.4 million new cancer cases by 2040. This rising prevalence of chronic diseases is expected to boost the demand for effective therapeutic solutions based on nanomedicine, thereby driving the growth of the nanomedicine market.

Major companies operating in the nanomedicine market are emphasizing innovative products, such as Dynapro ZetaStar, to enhance revenue generation. This advanced instrument enables simultaneous measurement of dynamic and static light scattering, along with dynamic and electrophoretic light scattering (DLS/SLS/ELS). For example, in September 2023, Waters Corporation, a US-based provider of analytical laboratory instruments and equipment, introduced Dynapro ZetaStar for nanoparticle analysis. The ZetaStar instrument supports the precise development of complex biologics by integrating multiple light scattering techniques, enabling adaptive data acquisition, automatically evaluating data quality, and improving measurement sensitivity and speed while requiring extremely small sample volumes. In addition, its distinctive flow cell design allows integration with an autosampler, significantly improving laboratory productivity and efficiency by facilitating dozens of unattended measurements over extended periods, including several hours or overnight.

In November 2023, Celgene, a US-based integrated biopharmaceutical company focused on the discovery and development of innovative therapies, acquired a stake in Nano Precision Medical for an undisclosed amount. Through this acquisition, Celgene enhances its presence in the nanomedicine market, enabling it to compete more effectively with other pharmaceutical companies investing in advanced drug delivery technologies. Nano Precision Medical is a US-based company that develops miniaturized, subdermal drug implants using its proprietary NanoPortal technology.

Major companies operating in the nanomedicine market are Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc.

North America was the largest region in the nanomedicine market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nanomedicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nanomedicine market consists of sales of gold, silica, iron oxide, polymeric, liposomes, and micelles. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nanomedicine Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nanomedicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nanomedicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanomedicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Nanoparticles; Nanoshells; Nanotubes; Nanodevices; Other Types
• 2) By Modality: Diagnostics; Treatments
• 3) By Application: Clinical Oncology; Infectious Diseases; Clinical Cardiology; Orthopedics; Other Applications
• Subsegments:
• 1) By Nanoparticles: Lipid-Based Nanoparticles; Polymeric Nanoparticles; Metallic Nanoparticles; Ceramic Nanoparticles
• 2) By Nanoshells: Gold Nanoshells; Silver Nanoshells; Silica Nanoshells
• 3) By Nanotubes: Carbon Nanotubes (CNTs); Polymer Nanotubes
• 4) By Nanodevices: Nanosensors; Nanorobots; Nanoscale Imaging Devices
• 5) By Other Types: Dendrimers; Quantum Dots; Nanocarriers
• Companies Mentioned: Pfizer Inc.; Ablynx NV; Amgen Inc.; Arrowhead Research Inc.; Bio-Gate AG; Celgene Corporation; F. Hoffmann-La Roche AG; GE Healthcare; Gilead Sciences Inc.; Merck AG; Nanospectra Biosciences; Nanotherapeutics Inc.; NanoViricides Inc; Novartis AG; Sanofi S. A.; Abraxis Bioscience Inc.; Alnylam Pharmaceuticals Inc.; Arrowhead Pharmaceuticals Inc.; AuraSense Therapeutics LLC; BIND Therapeutics Inc.; Camurus AB; Cerulean Pharma Inc.; CytImmune Sciences; Fujifilm Holdings; Nanobiosym Inc.; Nanobiotix SA; Nanogen Inc.; Nanoparticle BioChem Inc.; Nanospective Inc.; Nanosphere Health Sciences Inc.; Nanosys Inc.; PerkinElmer Inc.; Selecta Biosciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Nanomedicine Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Nanomedicine Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Nanomedicine Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Nanomedicine Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Targeted Drug Delivery Innovations
  • 4.2.2 Regenerative Nanomedicine Development
  • 4.2.3 Personalized Therapeutics Expansion
  • 4.2.4 Nanodevice-Based Diagnostics
  • 4.2.5 Nanoformulation Optimization

5. Nanomedicine Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Research Laboratories
• 5.3 Pharmaceutical Companies
• 5.4 Biotechnology Firms
• 5.5 Diagnostic Centers

6. Nanomedicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nanomedicine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Nanomedicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Nanomedicine Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Nanomedicine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Nanomedicine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nanomedicine Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nanomedicine Market Segmentation

• 9.1. Global Nanomedicine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types
• 9.2. Global Nanomedicine Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diagnostics, Treatments
• 9.3. Global Nanomedicine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications
• 9.4. Global Nanomedicine Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lipid-Based Nanoparticles, Polymeric Nanoparticles, Metallic Nanoparticles, Ceramic Nanoparticles
• 9.5. Global Nanomedicine Market, Sub-Segmentation Of Nanoshells, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Gold Nanoshells, Silver Nanoshells, Silica Nanoshells
• 9.6. Global Nanomedicine Market, Sub-Segmentation Of Nanotubes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Carbon Nanotubes (CNTs), Polymer Nanotubes
• 9.7. Global Nanomedicine Market, Sub-Segmentation Of Nanodevices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nanosensors, Nanorobots, Nanoscale Imaging Devices
• 9.8. Global Nanomedicine Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dendrimers, Quantum Dots, Nanocarriers

10. Nanomedicine Market Regional And Country Analysis

• 10.1. Global Nanomedicine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Nanomedicine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nanomedicine Market

• 11.1. Asia-Pacific Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nanomedicine Market

• 12.1. China Nanomedicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nanomedicine Market

• 13.1. India Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nanomedicine Market

• 14.1. Japan Nanomedicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nanomedicine Market

• 15.1. Australia Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nanomedicine Market

• 16.1. Indonesia Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nanomedicine Market

• 17.1. South Korea Nanomedicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nanomedicine Market

• 18.1. Taiwan Nanomedicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nanomedicine Market

• 19.1. South East Asia Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nanomedicine Market

• 20.1. Western Europe Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nanomedicine Market

• 21.1. UK Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nanomedicine Market

• 22.1. Germany Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nanomedicine Market

• 23.1. France Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nanomedicine Market

• 24.1. Italy Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nanomedicine Market

• 25.1. Spain Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nanomedicine Market

• 26.1. Eastern Europe Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nanomedicine Market

• 27.1. Russia Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nanomedicine Market

• 28.1. North America Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nanomedicine Market

• 29.1. USA Nanomedicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nanomedicine Market

• 30.1. Canada Nanomedicine Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nanomedicine Market

• 31.1. South America Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nanomedicine Market

• 32.1. Brazil Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nanomedicine Market

• 33.1. Middle East Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nanomedicine Market

• 34.1. Africa Nanomedicine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Nanomedicine Market, Segmentation By Type, Segmentation By Modality, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nanomedicine Market Regulatory and Investment Landscape

36. Nanomedicine Market Competitive Landscape And Company Profiles

• 36.1. Nanomedicine Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Nanomedicine Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Nanomedicine Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Ablynx NV Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Arrowhead Research Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Bio-Gate AG Overview, Products and Services, Strategy and Financial Analysis

37. Nanomedicine Market Other Major And Innovative Companies

• Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc.

38. Global Nanomedicine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nanomedicine Market

40. Nanomedicine Market High Potential Countries, Segments and Strategies

• 40.1 Nanomedicine Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Nanomedicine Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Nanomedicine Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer